Sunday
2:00 pm - 9:00 pm
Arrival and Check-in
6:00 pm - 7:00 pm
Dinner
7:30 pm - 7:40 pm
Introductory Comments by GRC Staff / Welcome and Introduction from the Chairs
7:40 pm - 9:30 pm
Keynote Session: Antibodies 2.0
7:40 pm - 7:50 pm
Introduction by Discussion Leader
7:50 pm - 8:30 pm
"Design of Antibody Therapeutics With Engineered Multispecificity"
8:30 pm - 8:40 pm
Discussion
8:40 pm - 9:20 pm
"Cell-Penetrating Peptide-Mediated Internalisation of Antibodies for Radioimmunotherapy of Pancreatic Cancer"
9:20 pm - 9:30 pm
Discussion
Monday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Anti-Infectious Repertoires and Therapeutics
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:30 am
"Evolution of Human B Cell Memory Over Time and Repeated Antigenic Encounters"
9:30 am - 9:40 am
Discussion
9:40 am - 10:05 am
"Antibody Repertoire Analysis: A Novel Route to Target Discovery"
10:05 am - 10:15 am
Discussion
10:15 am - 10:45 am
Coffee Break
10:45 am - 11:10 am
"Complexity Matters: How Natural Antibodies Eliminate Complex Pathogens"
11:10 am - 11:20 am
Discussion
11:20 am - 11:45 am
"Human Antibody Repertoire of SARS-CoV-2 XBB1.5 Booster Immunization"
11:45 am - 11:55 am
Discussion
11:55 am - 12:05 pm
"High-Throughput Characterization of Human anti-PfRH5 Antibodies Reveals a Potent Public Antibody Clonotype Against Blood-Stage Malaria"
12:05 pm - 12:10 pm
Discussion
12:10 pm - 12:20 pm
"Stalk Antibody-Mediated Broad Protection Against Influenza Viruses"
12:20 pm - 12:25 pm
Discussion
12:25 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
3:00 pm - 4:00 pm
The GRC Power Hourâ„¢
The GRC Power Hourâ„¢ is designed to address diversity and inclusion in the scientific workplace by providing a safe environment for informal and meaningful conversations amongst colleagues of all career stages. The program supports the professional growth of all members of our communities, including ethnicity, race and/or gender identity by providing an open forum for discussion and mentoring.
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"A TREM2-Activating Antibody with a Blood–Brain Barrier Transport Vehicle Enhances Microglial Metabolism in Alzheimer’s Disease Models"
6:30 pm - 6:35 pm
Discussion
6:35 pm - 6:55 pm
"Bypassing the Blood Brain Barrier: Exploiting CNS Penetrant AAV Vectors for Localised Biologics Production and Activity"
6:55 pm - 7:00 pm
Discussion
7:00 pm - 7:10 pm
"A Non-Invasive Subunit Vaccine Technology Targeting FcRn Induces Protective Mucosal and Systemic Antibody Immunity in Mouse Models"
7:10 pm - 7:15 pm
Discussion
7:15 pm - 7:25 pm
"TrogoTACs: Bispecific Chimeras for Targeted Protein Transfer"
7:25 pm - 7:30 pm
Discussion
7:30 pm - 7:40 pm
"Engineering Trojan Horse Nanoparticles for Targeted Endosomal Delivery of Viral Fusion Inhibitors"
7:40 pm - 7:45 pm
Discussion
7:45 pm - 7:55 pm
"The Pathomechanisms of MuSK Antibodies and How They Can Be Used As Therapeutics"
7:55 pm - 8:00 pm
Discussion
8:00 pm - 9:00 pm
Dinner
Tuesday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Group Photo
9:00 am - 12:30 pm
Abs Formats for Cancer and Autoimmunity
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:30 am
"Natural Killer Cell Engagers"
9:30 am - 9:40 am
Discussion
9:40 am - 10:05 am
"Engineering More Stable Antibody Drug Conjugates to Address Platform Toxicities is Conceptually Simple but Hard to Translate to the Clinic"
10:05 am - 10:15 am
Discussion
10:15 am - 10:45 am
Coffee Break
10:45 am - 11:10 am
"A Novel Bispecific to Target the Brain Tumor Microenvironment"
11:10 am - 11:20 am
Discussion
11:20 am - 11:45 am
"Modulation of IgG Effector Functions by Fc Glycosylation"
11:45 am - 11:55 am
Discussion
11:55 am - 12:05 pm
"Mesothelin-Targeted Nanobody-Drug Conjugates for the Treatment of Pancreatic Cancer"
12:05 pm - 12:10 pm
Discussion
12:10 pm - 12:20 pm
"A Bispecific T-Cell Engager (BiTE) Targeting CD19 and CD3 is Arresting Disease Progression in a Mouse Model of Autoimmune Blistering Disease"
12:20 pm - 12:25 pm
Discussion
12:25 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
6:00 pm - 6:25 pm
"The Unique Properties of IgG4 and its Roles in Health and Disease"
6:25 pm - 6:35 pm
Discussion
6:35 pm - 7:00 pm
"Development of Anti-FcRn Antibodies for Blocking FcRn in Autoimmune Diseases"
7:00 pm - 7:10 pm
Discussion
7:10 pm - 7:25 pm
"Distinct Transport Properties of the Two Ligands of FcRn: From Biology to Therapeutic Implication"
7:25 pm - 7:30 pm
Discussion
7:30 pm - 7:40 pm
"Elevating Fc Effector Functions by Exploiting the Natural Amino-Acid Sequence Variation in IgG Subclasses"
7:40 pm - 7:45 pm
Discussion
7:45 pm - 7:55 pm
"Two Faces of IgM: Distinct Molecular Features, Clonalities, and Specificities When Present in Circulation or Secretions"
7:55 pm - 8:00 pm
Discussion
8:00 pm - 9:00 pm
Dinner
Wednesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Engineering Abs for Enhanced Function
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:30 am
"TCR-Mimic Nanobody-Based Bispecific T Cell Engager for Tumor Immunotherapy"
9:30 am - 9:40 am
Discussion
9:40 am - 10:05 am
"The Evolution of Antibody Discovery in Veterinary Medicine"
10:05 am - 10:15 am
Discussion
10:15 am - 10:45 am
Coffee Break
10:45 am - 11:10 am
"Mutually Dependent Antibody Pairs that Selectively Act on Cells Co-Expressing Two Surface Antigens"
11:10 am - 11:20 am
Discussion
11:20 am - 11:45 am
"Energy-Based Ab Improvement"
11:45 am - 11:55 am
Discussion
11:55 am - 12:05 pm
"Investigating the Novel "X" Trispecific T Cell Engaging Antibody for an Enhanced Anti-Tumor Response"
12:05 pm - 12:10 pm
Discussion
12:10 pm - 12:15 pm
General Discussion
12:15 pm - 12:25 pm
"A Tetravalent (2+2) Bispecific Antibody Format with Excellent Functionality and IgG-Like Stability, Pharmacology and Developability Properties"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Innovative Technologies for B Cell and Antibody Identification
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"High-Throughput Profiling of Antigen-Specific Antibody Secreting Cells"
6:30 pm - 6:40 pm
Discussion
6:40 pm - 7:05 pm
"The Use of Microfluidics to Identify Rare B Cells Targeting Infectious Pathogens"
7:05 pm - 7:15 pm
Discussion
7:15 pm - 7:25 pm
"Conformational Tuning of Antibody Fab-Arms Facilitates Immune Agonist Activity"
7:25 pm - 7:30 pm
Discussion
7:30 pm - 7:40 pm
"Modified Self-Amplifying RNA for In situ Antibody Production"
7:40 pm - 7:45 pm
Discussion
7:45 pm - 7:55 pm
"Insights Into the In Vivo Mode of Action of Mono and Bispecific Antibodies Through Kinetic Analysis of Affinity and Avidity"
7:55 pm - 8:00 pm
Discussion
8:00 pm - 9:00 pm
Dinner
Thursday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Business Meeting
Nominations for the Next Vice Chair(s); Complete the GRC Evaluation Forms; Election of the Next Vice Chair(s)
9:00 am - 12:30 pm
Computational and Systems Analyses
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:30 am
"Discovery and Characterization of CD28 Multispecific Antibodies for Treatment of Solid Tumors"
9:30 am - 9:40 am
Discussion
9:40 am - 10:05 am
"Dissecting Antibody Functions in Tuberculosis"
10:05 am - 10:15 am
Discussion
10:15 am - 10:45 am
Coffee Break
10:45 am - 11:10 am
"Antibody Feedback Shaping Antibody Diversity"
11:10 am - 11:20 am
Discussion
11:20 am - 11:45 am
"Electron Microscopy and Computational Approaches to Vaccine Design"
11:45 am - 11:55 am
Discussion
11:55 am - 12:05 pm
"Mutability and Hypermutation Antagonize Immunoglobulin Codon Optimality"
12:05 pm - 12:10 pm
Discussion
12:10 pm - 12:20 pm
"Guiding Human Antibody Affinity Optimization by Understanding Rare Mutations Suggested by Complex Evolutionary Rules"
12:20 pm - 12:25 pm
Discussion
12:25 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Vaccination Shapes B and Ab Responses
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"The Past, Present and Future of Antiviral Monoclonal Antibodies"
6:30 pm - 6:40 pm
Discussion
6:40 pm - 7:05 pm
"Human Antibodies for Emerging Infectious Diseases"
7:05 pm - 7:15 pm
Discussion
7:15 pm - 7:25 pm
"Interrogation of Human Monoclonal Antibodies Induced by Meningococcus B Vaccination to Identify Cross-Protective Antigens Against Gonococcus"
7:25 pm - 7:30 pm
Discussion
7:30 pm - 7:40 pm
"An Engineered Hyperglycosylated Immunogen to Epitope-Focus Anti-Neuraminidase Humoral Immunity"
7:40 pm - 7:45 pm
Discussion
7:45 pm - 7:55 pm
"A Chimeric HA UIV Elicits Multi-Pronged Polyclonal Antibody Responses to Conserved Head and Stem Epitopes on HA"
7:55 pm - 8:00 pm
Discussion
8:00 pm - 9:00 pm
Dinner
Friday
7:30 am - 8:30 am
Breakfast
9:00 am
Departure